On May 5, 2025, IGM Biosciences, Inc. received notice of termination of a collaboration agreement with Genzyme Corporation, leading to an 80% workforce reduction and closure of most facilities to preserve cash. This reflects the companies' decision that continuing the agreement was not beneficial for either side.